Convalescent plasma therapy for COVID-19: a tried-and-true old strategy?

Xi, Yongzhi

Xi, Yongzhi.

Xi Y; Department of Immunology and National Center for Biomedicine Analysis, Fifth Medical Center of Chinese PLA General Hospital, No. 8, Dongda Ave, Fengtai District, 100071, Beijing, P.R. China. xiyz@yahoo.com.

Signal Transduct Target Ther ; 5(1): 203, 2020 09 15.

Article in English | MEDLINE | ID: covidwho-772979

Subject(s)

Antibodies, Neutralizing/therapeutic use; Antibodies, Viral/therapeutic use; Coronavirus Infections/therapy; Cytokine Release Syndrome/therapy; Lymphopenia/therapy; Pneumonia, Viral/therapy; Antibody-Dependent Enhancement/drug effects; Antiviral Agents/therapeutic use; Betacoronavirus/drug effects; Betacoronavirus/immunology; Betacoronavirus/pathogenicity; COVID-19; Complement Pathway, Alternative/drug effects; Coronavirus Infections/diagnosis; Coronavirus Infections/immunology; Coronavirus Infections/mortality; Cytokine Release Syndrome/diagnosis; Cytokine Release Syndrome/immunology; Cytokine Release Syndrome/mortality; Disease Progression; Immunization, Passive/methods; Lymphopenia/diagnosis; Lymphopenia/immunology; Lymphopenia/mortality; Pandemics; Pneumonia, Viral/diagnosis; Pneumonia, Viral/immunology; Pneumonia, Viral/mortality; Receptors, IgG/genetics; Receptors, IgG/immunology; SARS-CoV-2; Severity of Illness Index; Survival Analysis; COVID-19 Serotherapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Antibodies, Neutralizing / Cytokine Release Syndrome / Lymphopenia / Antibodies, Viral Type of study: Diagnostic study / Prognostic study Language: English Journal: Signal Transduct Target Ther Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google